INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 132 filers reported holding INTERSECT ENT INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,990,000 | +0.8% | 106,747 | -1.7% | 0.00% | 0.0% |
| Q4 2021 | $2,966,000 | +433.5% | 108,592 | +431.1% | 0.00% | – |
| Q3 2021 | $556,000 | +28.7% | 20,448 | -19.1% | 0.00% | – |
| Q2 2021 | $432,000 | -20.1% | 25,279 | -2.5% | 0.00% | – |
| Q1 2021 | $541,000 | -22.5% | 25,931 | -14.9% | 0.00% | – |
| Q4 2020 | $698,000 | +90.2% | 30,471 | +35.5% | 0.00% | – |
| Q3 2020 | $367,000 | -69.3% | 22,493 | -74.5% | 0.00% | -100.0% |
| Q2 2020 | $1,194,000 | +818.5% | 88,175 | +701.2% | 0.00% | – |
| Q1 2020 | $130,000 | -94.7% | 11,005 | -88.7% | 0.00% | -100.0% |
| Q4 2019 | $2,434,000 | +89.6% | 97,803 | +29.4% | 0.00% | +100.0% |
| Q3 2019 | $1,284,000 | +124.9% | 75,563 | +199.6% | 0.00% | – |
| Q2 2019 | $571,000 | -78.8% | 25,220 | -69.9% | 0.00% | -100.0% |
| Q1 2019 | $2,689,000 | +170.0% | 83,730 | +136.7% | 0.00% | +100.0% |
| Q4 2018 | $996,000 | -87.6% | 35,376 | -87.4% | 0.00% | -50.0% |
| Q3 2018 | $8,048,000 | -37.4% | 280,023 | -18.4% | 0.00% | -50.0% |
| Q2 2018 | $12,849,000 | +28.2% | 343,129 | +34.5% | 0.00% | -20.0% |
| Q1 2018 | $10,026,000 | +70.2% | 255,168 | +40.3% | 0.01% | +25.0% |
| Q4 2017 | $5,892,000 | -21.1% | 181,894 | -24.2% | 0.00% | -20.0% |
| Q3 2017 | $7,472,000 | -7.2% | 239,947 | -16.8% | 0.01% | -16.7% |
| Q2 2017 | $8,055,000 | +84.8% | 288,236 | +13.4% | 0.01% | +100.0% |
| Q1 2017 | $4,358,000 | +50.9% | 254,248 | +6.4% | 0.00% | +50.0% |
| Q4 2016 | $2,888,000 | +27.9% | 238,922 | +67.5% | 0.00% | 0.0% |
| Q3 2016 | $2,258,000 | +87.2% | 142,641 | +52.7% | 0.00% | +100.0% |
| Q2 2016 | $1,206,000 | +11.9% | 93,394 | +64.5% | 0.00% | 0.0% |
| Q1 2016 | $1,078,000 | -5.4% | 56,777 | +11.9% | 0.00% | 0.0% |
| Q4 2015 | $1,140,000 | +975.5% | 50,756 | +1018.7% | 0.00% | – |
| Q3 2015 | $106,000 | -91.6% | 4,537 | -89.7% | 0.00% | -100.0% |
| Q2 2015 | $1,260,000 | +77.5% | 44,069 | +60.2% | 0.00% | – |
| Q1 2015 | $710,000 | +2118.8% | 27,501 | +1425.3% | 0.00% | – |
| Q4 2014 | $32,000 | -94.6% | 1,803 | -95.3% | 0.00% | – |
| Q3 2014 | $595,000 | – | 38,458 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |